Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients (HEALTH-DB ACS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01678339 |
Recruitment Status :
Withdrawn
First Posted : September 5, 2012
Last Update Posted : October 3, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Acute Coronary Syndrome Acute Myocardial Infarction |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Cohort |
Time Perspective: | Retrospective |
Official Title: | Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients |
Study Start Date : | September 2012 |
Estimated Study Completion Date : | December 2012 |
Group/Cohort |
---|
1 |
- The diagnostic path for each patient included in the analysis will be described by using all prescription for laboratory test (eg. total cholesterol, LDL cholesterol) and/or diagnostics tests (eg. electrocardiogram) during the observation period. [ Time Frame: up to 2 years ]
- The drugs treatment path will be described by using all prescriptions of antihypertensive drugs, lipid-lowering drugs and antiplatelet drugs during the observation period. [ Time Frame: up to 2 years ]
- Adherence to treatment will be calculated in the manner suggested by the literature and used in previous publications. Different methods of assessment will, however, used in order to study the variability of results. The analysis will be conducted over [ Time Frame: up to 2 years ]
- The chronological analysis of the requirements will allow the identification of potential therapeutic combinations or substitutions. [ Time Frame: up to 2 years ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Subjects discharged alive from hospitalization for ACS
Exclusion Criteria:
- All patients that don't have a continuative presence as beneficiaries of the region between January 1st, 2007 and December 31st 2011 will be excluded from analysis.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678339
Italy | |
Research Site | |
Palermo, Italy |
Study Chair: | Flore La Tour | AstraZeneca CLINICAL RESEARCH DIRECTOR | |
Study Director: | Raffaele Sabia | AstraZeneca Italy - VP MEDICAL | |
Principal Investigator: | Rosalia Traiana, Doctor of Pharmacology | Department of Pharmaceutical Health - SICILIAN REGION |
Responsible Party: | AstraZeneca |
ClinicalTrials.gov Identifier: | NCT01678339 |
Other Study ID Numbers: |
NIS-CIT-XXX-2012/1 |
First Posted: | September 5, 2012 Key Record Dates |
Last Update Posted: | October 3, 2012 |
Last Verified: | October 2012 |
ACS AMI |
Myocardial Infarction Acute Coronary Syndrome Syndrome Infarction Disease Pathologic Processes |
Ischemia Necrosis Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |